上交所：对ST葫芦娃及有关责任人予以通报批评

Core Viewpoint - The Shanghai Stock Exchange has issued a decision to publicly criticize Hainan Huluwa Pharmaceutical Group Co., Ltd. (stock abbreviation: ST Huluwa) for inaccurate financial data disclosures in multiple periodic reports, involving significant amounts and high correction ratios [1] Summary by Relevant Sections - Company Accountability - The decision highlights that the then Chairman and General Manager Liu Jingping, along with the then Chief Financial Officer Yu Hui, failed to fulfill their duties and are responsible for the company's violations [1] - Disciplinary Actions - The Shanghai Stock Exchange has decided to publicly criticize Hainan Huluwa Pharmaceutical Group Co., Ltd., Liu Jingping, and Yu Hui for their roles in the inaccurate financial disclosures [1]